Clearpoint Neuro Inc (CLPT)

Currency in USD
14.21
+0.82(+6.12%)
Closed·
14.30+0.09(+0.63%)
·

CLPT Earnings

Latest Release
Aug 03, 2026
EPS / Forecast
-0.38 / -0.29
Revenue / Forecast
10.9M / 12.73M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/-0.263--/13.63M----Free Sign Up
2026/06-0.380/-0.29010.90M/12.73M-31.03%-14.38%Free Sign Up
2026/03-0.320/-0.23012.13M/12.20M-39.13%-0.57%Free Sign Up
2025/12-0.260/-0.18510.40M/10.35M-40.54%+0.48%Free Sign Up
2025/09-0.210/-0.1808.86M/9.80M-16.67%-9.59%Free Sign Up
2025/06-0.210/-0.2009.20M/9.23M-5%-0.33%Free Sign Up
2025/03-0.220/-0.1628.49M/8.24M-35.64%+3.03%Free Sign Up
2024/12-0.200/-0.1747.77M/8.23M-15.14%-5.59%Free Sign Up
2024/09-0.180/-0.1708.12M/7.78M-5.88%+4.37%Free Sign Up
2024/06-0.160/-0.2007.86M/7.33M+20%+7.23%Free Sign Up

All numbers in USD

Clearpoint Neuro Inc Earnings Call Summary for Q2/2026

  • Clearpoint Neuro Q2 2026 revenue rose 18% YoY to $10.9M but missed estimates by 14.4%; EPS loss of $0.38 exceeded forecast by $0.09.
  • Shares plunged 15.5% after-hours to $13 following the dual miss; operating expenses surged 68% in sales/marketing, 64% in G&A.
  • Management issued 2026 revenue guidance of $48M-$52M, shifting focus to clinical support and new CAL facility over traditional device sales.
  • New California CAL facility could generate $60M+ annually at capacity; first GLP work expected H1 2027 with commercial launches from partners.
  • Cash fell to $29.4M from $45.9M year-end 2025; CEO signals pivot to B2B pharma model potentially representing half of future revenue.
Last Updated: 2026-08-03, 05:30 p/m
Read Full Transcript

FAQ

What Is Clearpoint Neuro's Earnings Per Share (TTM)?

The Clearpoint Neuro EPS (TTM) is -1.18.

When Is The Next Clearpoint Neuro Earnings Date?

Clearpoint Neuro will release its next earnings report on Nov 05, 2026.

What Is Clearpoint Neuro’s Revenue Forecasts For Upcoming Quarters?

Clearpoint Neuro’s revenue forecast is 13.63M.

How Did Clearpoint Neuro React to the Company's Latest Earnings Report?

Clearpoint Neuro reported a -31.03% EPS surprise and a -14.38% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -13.82%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.